Influence of the -308 TNF-α and -174 IL-6 polymorphisms on lipid profile in Mexican subjects

Hereditas

Volumn 143, Issue 2006, 2006, Pages 167-172

  Parra Rojas, I ^a   Ruiz Madrigal B ^a   Martinez Lopez E ^a   Panduro, A ^a  

^a HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; MEXICO; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LIPIDS; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248184128     PISSN: 00180661     EISSN: 16015223     Source Type: Journal    
DOI: 10.1111/j.2006.0018-0661.01936.x     Document Type: Article

References (47)

1. Aguilar-Salinas, C. A., Olaiz, G., Valles, V. et al. 2001. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. - J. Lipid. Res. 42: 1298-1307.
2. Basso, F., Lowe, G. D., Rumley, A. et al. 2002. Interleukin-6 -174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). - Arterioscler. Thromb. Vasc. Biol. 22: 599-604.
3. Corbett, E. L., Mozzato-Chamay, N., Butterworth, A. E. et al. 2002. Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. - Am. J. Respir. Crit. Care. Med. 165: 690-693.
4. Cozen,W., Gill, P. S., Ingles, S. A. et al. 2004. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. - Blood 103: 3216-3221.
5. Dedoussis, G. V., Manios, Y., Choumerianou, D. M. et al. 2004. The IL-6 gene G-174C polymorphism related to health indices in Greek primary school children. - Obes. Res. 12: 1037-1041.
6. Feingold, K. R. and Grunfeld, C. 1992. Role of cytokines in inducing hyperlipidemia. - Diabetes 41: 97-101.
7. Fernandez-Real, J. M., Broch, M., Vendrell, J. et al. 2000. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. - J. Clin. Endocrinol. Metab. 85: 1334-1339.
8. Fishman, D., Faulds, G., Jeffery, R. et al. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. - J. Clin. Invest. 102: 1369-1376.
9. Flex, A., Gaetani, E., Pola, R. et al. 2002. The -/174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery oclusive disease. - Eur. J. Vasc. Endovasc. Surg. 24: 264-268.
10. Furuta, M., Yano, Y., Ito, K. et al. 2002. Relationship of the tumor necrosis factor -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. - Diabetes Res. Clin. Pract. 56: 141-145.
11. Gonzalez, S., Rodrigo, L., Martinez-Borra, J. et al. 2003. TNF-/308A promoter polymorphism is ssociated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. - Am. J. Gastroenterol. 98: 1101-1106.
12. Gorodezky, C., Alaez, C., Vazquez-Garcia, M. N. et al. 2001. The genetic structure of Mexican Mestizos of different locations: Tracking back their origins through MHC genes, blood group systems, and microsatellites. - Hum. Immunol. 62: 979-991.
13. Greenberg, A. S., Nordan, R. P., McIntosh, J. et al. 1992. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin-6 in cancer cachexia. - Cancer Res. 52: 4113-4116.
14. Greisenegger, S., Endler, G., Haering, D. et al. 2003. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. - Thromb. Res. 110: 181-186.
15. Grove, J., Daly, A. K., Bassendine, M. F. et al. 1997. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. - Hepatology 26: 143-146.
16. Hayakawa, T., Takamura, T., Hisada, A. et al. 2002. IL-6 gene polymorphism -174G/C does not contribute substantially to hyperlipidaemia and type II diabetes mellitus in Japanese men. - Diabetologia 45: 453-154.
17. Hotamisligil, G. S., Budavari, A., Murray, D. et al. 1994. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor α. - J. Clin. Invest. 94: 1543-1549.
18. Hulkkonen, J., Pertovaara, M., Antonen, J. et al. 2001. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. - Rheumatology 40: 656-661.
19. Jenny, N. S., Tracy, R. P., Ogg, M. S. et al. 2002. In the elderly, Interleukin-6 plasma levels and -174G > C polymorphism are associated with the development of cardiovascular disease. - Arterioscler. Thromb. Vasc. Biol. 22: 2066-2071.
20. Karahan, Z. C., Deda, G., Sipahi, T. et al. 2005. TNF-alpha -308 G/A and IL-/174 G/C polymorphisms in the Turkish pediatric stroke patients. - Thromb. Res. 115: 393-398.
21. Kuffner, T., Whitworth, W., Jairam, M. et al. 2003. HLA class II and TNF genes in African Americans from the southeastern United States: Regional differences in allele frequencies. - Hum. Immunol. 64: 639-647.
22. Lander, E. S. 1996. The new genomics: Global views of biology. - Science 274: 536-539.
23. Landi, S., Moreno, V., Gioia-Patricola, L. et al. 2003. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. - Cancer Res. 63: 3560-3566.
24. Lio, D., Scola, L., Crivello, A. et al. 2003. Inflammation, genetics, and longevity: Further studies on the protective effects in men of IL-10 promoter SNP and its interaction with TNF-α -308 promoter SNP. J. Med. Genet. 40: 296-299.
25. Lisker, R. 1981. Estructura genética de la población mexicana. Salvat.
26. Lozano, F. J. M. and Lopez, R. A. 1978. Historia de América. CECSA.
27. Miller, S. A., Dykes, D. D. and Polesky, H. F. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
28. Mohlig, M., Boeing, H., Spranger, J. et al. 2004. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. - J. Clin. Endocrinol. Metab. 89: 1885-1890.
29. Nonogaki, K., Fuller, G. M., Fuentes, N. L. et al. 1995. Interleukin-6 stimulates hepatic triglyceride secretion in rats. - Endocrinology 136: 2143-2149.
30. Padovani, J. C., Pazin-Filho, A., Simoes, M. V. et al. 2000. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. - Thromb. Res. 100: 263-269.
31. Pantelidis, P., Fanning, G. C., Wells, A. U. et al. 2001. Analysis of tumor necrosis factor-alpha, lymphotoxinalpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. - Am. J. Respir. Crit. Care. Med. 163: 1432-1436.
32. Pola, R., Flex, A., Gaetani, E. et al. 2003. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. - Stroke 34: 881-885.
33. Posadas-Romero, C., Tapia-Conyer, I., Lerman-Garber, I. et al. 1995. Cholesterol levels and prevalence of hypercholesterolemia in a Mexican adult population. - Atherosclerosis 118: 275-284.
34. Quibrera, I. R., Hernández, H. G. and Aradillas, C. G. 1994. Prevalencia de diabetes, intolerancia a la glucosa, hiperlipidemia y factores de riesgo en función de nivel socioeconómico. - Rev. Invest. Clin. 44: 321-328.
35. Rasmussen, S. K., Urhammer, S. A., Jensen, J. N. et al. 2000. The -238 and -308 G→A polymorphisms of the tumor necrosis factor alpha gene promotor are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. - J. Clin. Endocrinol. Metab. 85: 1731-1734.
36. Rivet, P. 1960. Los origenes del hombre americano. Fondo de Cultura Económica.
37. Romeo, S., Sentinelli, F., Capici, F. et al. 2001. The G-308A variant of the tumor necrosis factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution. - B. M. C. Med. Genet. 2: 10.
38. Rotter, V., Nagaev, I. and Smith, U. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. - J. Biol. Chem. 278: 45777-45784.
39. Schotte, H., Schluter, B., Rust, S. et al. 2001. Interleukin-6 promoter (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. - Rheumatology 40: 393-400.
40. Terry, C. F., Loukaci, V. and Green, F. R. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. - J. Biol. Chem. 275: 18138-18144.
41. Um, J. Y. and Kim, H. M. 2003. Frequencies of the tumor necrosis factor gene polymorphisms in the Korean population. - Hereditas 139: 184-188.
42. Vendrell, J., Fernandez-Real, J. M., Gutierrez, C. et al. 2003. A polymorphism in the promoter of the tumor necrosis factor-alpha (-308) is associated with coronary heart disease in type 2 diabetic patients. - Atherosclerosis 167: 257-264.
43. Walston, J., Seibert, M., Yen, C. J. et al. 1999. Tumor necrosis factor-alpha -238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance. - Diabetes 48: 2096-2098.
44. Wilson, A. G., Symons, J. A., McDowell, T. L. et al. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. - Proc. Natl Acad. Sci. USA 94: 3195-3199.
45. Zhai, R., Liu, G., Yang, C. et al. 2001. The G to C polymorphism -174 of the interleukin-6 gene is rare in a southern Chinese population. - Pharmacogenetics 11: 699-701.
46. Zinman, B., Hanley, A. J., Harris, S. B. et al. 1999. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. - J. Clin. Endocrinol. Metab. 84: 272-278.
47. Zipperlen, K., Peddle, L., Melay, B. et al. 2005. Association of TNF-alpha polymorphisms in Crohn disease. - Hum. Immunol. 66: 56-59.